Page 49 - Read Online

Borek et al. Rare Dis Orphan Drugs J 2023;2:5 https://dx.doi.org/10.20517/rdodj.2022.20 Page 13 of 14

hypertension. Chest 2012;141:651-60. DOI PubMed
94. Caughey GH. Mast cell proteases as pharmacological targets. Eur J Pharmacol 2016;778:44-55. DOI PubMed PMC
95. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human
T and TC mast cells. J Immunol 1987;138:2611-5. PubMed
96. Schwartz L, Lewis R, Austen K. Tryptase from human pulmonary mast cells. Purification and characterization. J Biol Chem
1981;256:11939-43. PubMed
97. Lützelschwab C, Pejler G, Aveskogh M, Hellman L. Secretory granule proteases in rat mast cells. Cloning of 10 different serine
proteases and a carboxypeptidase A from various rat mast cell populations. J Exp Med 1997;185:13-29. DOI PubMed PMC
98. Pejler G, Rönnberg E, Waern I, Wernersson S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood
2010;115:4981-90. DOI PubMed
99. Kosanovic D, Dahal BK, Peters DM, et al. Histological characterization of mast cell chymase in patients with pulmonary
hypertension and chronic obstructive pulmonary disease. Pulm Circ 2014;4:128-36. DOI PubMed PMC
100. Compton SJ, Cairns JA, Holgate ST, Walls AF. Human mast cell tryptase stimulates the release of an IL-8-dependent neutrophil
chemotactic activity from human umbilical vein endothelial cells (HUVEC). Clin Exp Immunol 2000;121:31-6. DOI PubMed PMC
101. Compton SJ, Cairns JA, Holgate ST, Walls AF. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine
release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective
release of IL-8 from human umbilical vein endothelial cells. J Immunol 1998;161:1939-46. DOI
102. Iddamalgoda A, Le QT, Ito K, Tanaka K, Kojima H, Kido H. Mast cell tryptase and photoaging: possible involvement in the
degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res 2008;300 Suppl 1:S69-76. DOI PubMed
103. Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest
1997;99:1313-21. DOI PubMed PMC
104. Abe M, Kurosawa M, Ishikawa O, Miyachi Y, Kido H. Mast cell tryptase stimulates both human dermal fibroblast proliferation and
type I collagen production. Clin Exp Allergy 1998;28:1509-17. DOI PubMed
105. Bagher M, Larsson-Callerfelt AK, Rosmark O, Hallgren O, Bjermer L, Westergren-Thorsson G. Mast cells and mast cell tryptase
enhance migration of human lung fibroblasts through protease-activated receptor 2. Cell Commun Signal 2018;16:59. DOI PubMed
PMC
106. D'Orléans-Juste P, Houde M, Rae GA, Bkaily G, Carrier E, Simard E. Endothelin-1 (1-31): from chymase-dependent synthesis to
cardiovascular pathologies. Vascul Pharmacol 2008;49:51-62. DOI PubMed
107. Simard E, Jin D, Takai S, Miyazaki M, Brochu I, D’Orle-Juste P. Chymase-dependent conversion of big Endothelin-1 in the mouse in
Vivo. J Pharmacol Exp Ther 2009;328:540-8. DOI PubMed
108. Koga T, Urata H, Inoue Y, et al. Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy.
Hypertens Res 2003;26:759-68. DOI PubMed
109. Heutinck KM, ten Berge IJ, Hack CE, Hamann J, Rowshani AT. Serine proteases of the human immune system in health and disease.
Mol Immunol 2010;47:1943-55. DOI PubMed
110. Lazaar AL, Plotnick MI, Kucich U, et al. Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced
proliferation of human airway smooth muscle cells. J Immunol 2002;169:1014-20. DOI PubMed
111. Frank BT, Rossall JC, Caughey GH, Fang KC. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated
extracellularly by alpha-chymase. J Immunol 2001;166:2783-92. DOI PubMed
112. Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G. A key role for mast cell chymase in the activation of
pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 2005;280:9291-6. DOI PubMed
113. Kosanovic D, Luitel H, Dahal BK, et al. Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis.
Eur Respir J 2015;46:1084-94. DOI PubMed
114. Weng M, Baron DM, Bloch KD, Luster AD, Lee JJ, Medoff BD. Eosinophils are necessary for pulmonary arterial remodeling in a
mouse model of eosinophilic inflammation-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2011;301:L927-
36. DOI PubMed PMC
115. Shu T, Zhang J, Zhou Y, et al. Eosinophils protect against pulmonary hypertension through 14-HDHA and 17-HDHA. Eur Respir J
2023;61:2200582. DOI PubMed PMC
116. Ikutani M, Ogawa S, Yanagibashi T, et al. Elimination of eosinophils using anti-IL-5 receptor alpha antibodies effectively suppresses
IL-33-mediated pulmonary arterial hypertrophy. Immunobiology 2018;223:486-92. DOI PubMed
117. Alzghoul BN, As Sayaideh M, Moreno BF, et al. Pulmonary hypertension in eosinophilic versus noneosinophilic COPD. ERJ Open
Res 2021;7:00772-2020. DOI PubMed PMC
118. Wang T, Han SX, Zhang SF, et al. Role of chymase in cigarette smoke-induced pulmonary artery remodeling and pulmonary
hypertension in hamsters. Respir Res 2010;11:36. DOI PubMed PMC
119. Lan NSH, Massam BD, Kulkarni SS, Lang CC. Pulmonary arterial hypertension: pathophysiology and treatment. Diseases
2018;6:38. DOI PubMed PMC
120. Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education
Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65. DOI PubMed
121. Chalmers JD, Haworth CS, Metersky ML, et al; WILLOW Investigators. Phase 2 trial of the DPP-1 inhibitor brensocatib in
bronchiectasis. N Engl J Med 2020;383:2127-37. DOI PubMed